Arc Institute partners with NVIDIA to accelerate the future of computational biomedical research
Business Announcement
Updates every hour. Last Updated: 10-Jul-2025 13:11 ET (10-Jul-2025 17:11 GMT/UTC)
Ecologists at the School of Biological Sciences of The University of Hong Kong (HKU) have made valuable discoveries that could transform the conservation of two iconic cockatoo species: the Sulphur-crested cockatoos and the critically endangered Yellow-crested cockatoos – with only 2,000 individuals remaining in the wild for the latter.
Until now, no whole-genome research had been conducted on either species, which were identified solely by subtle morphological differences. Through two innovative studies, the team uncovered new genetic insights, reshaping our understanding of these species and offering fresh hope for their survival amid severe threats from habitat loss and illegal trapping. These findings, recently published in high-impact scientific journals Molecular Biology and Evolution, and Molecular Ecology, will be highly influential in guiding future conservation efforts.
In a paper published in SCIENCE CHINA Life Science, an international team of scientists provided a comprehensive overview of single-cell and spatial genomics. They review breakthroughs in single-cell multi-omics technologies, spatial genomics methods, and the computational strategies employed toward the analyses of single-cell atlas data. Additionally, they emphasize the progress in constructing cellular atlases and their clinical applications, particularly in the context of disease. Lastly, they discuss emerging trends, challenges, and opportunities in this rapidly evolving field.
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer drugs compared to others on Traditional Medicare.
The findings were published today in JAMA Health Forum.
"Lung cancer is the leading cause of cancer-related deaths in the United States and colorectal cancer ranks third. Gaining a better understanding of treatment options and their costs under different insurance plans is important for assessing the overall healthcare landscape and how insurances manage patient costs,” said the study’s first author Cathy Bradley, PhD, Dean of the Colorado School of Public Health.
The study found Medicare Advantage patients received less expensive cancer drugs, particularly for colorectal cancer, when compared to Traditional Medicare. But this was not the case for non-small cell lung cancer. The researchers found there are less low-cost treatment alternatives available, resulting in high-cost drugs regardless of insurance.